Fingerprint
Dive into the research topics of 'Poziotinib for Patients With HER2 Exon 20 Mutant Non–Small-Cell Lung Cancer: Results From a Phase II Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Poziotinib for Patients With HER2 Exon 20 Mutant Non–Small-Cell Lung Cancer: Results From a Phase II Trial
Yasir Y. Elamin, Jacqulyne Ponville Robichaux, Brett W. Carter, Mehmet Altan, Don L. Gibbons, Frank V. Fossella, Vincent K Lam, Anisha B. Patel, Marcelo V. Negrao, Xiuning Le, Frank E. Mott, Jianjun Zhang, Lei Feng, George Blumenschein, Anne S. Tsao, John V. Heymach
Research output: Contribution to journal › Article › peer-review
54
Scopus
citations